… regulatory approval for the patent of reportedly, the world … gene therapies and introduces a new treatment approach for blood cancers … for Research on Cancer (IARC), blood cancers account for 8 … bi-specific approach to cancer immunotherapy. Unlike conventional …

… secured regulatory approval for the patent of the world’s … are approved by the Indian Patent Office (IPO) under the … of the Controller General of Patents, Designs & Trade Marks ( … and gene therapies and offers new hope to patients battling blood cancers …

… cell death genes as possible candidate biomarkers for cancer diagnosis, prognosis … Liu H. Pan-cancer profiles of the cuproptosis gene set. Am J … Cancer Res. 2022;12 … as therapeutic agents. A patent review for the period from …

… Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales & … Markets Approved Antibodies Dosage, Patent, Pricing & Sales … cell lung cancer (NSCLC) that harbor NRG1 gene fusions and … to treat genetically driven cancers that have shown resistance …

… the “undruggable” RAS genes Patients with pancreatic cancer have an overall poor … mutations, the most common cancer-causing gene mutation across cancer types, which researchers … is an inventor on patents relating to cancer cellular immunotherapy and KRAS …

… be damned. Jiankui used CRISPR gene-editing technology to edit the … out that fiddling with those genes to make the girls immune … could cause them to develop cancer while still not protecting from … took his name off the patent because he felt it was …

… testing: Empowering personalized cancer treatment "Circulating … further supporting the personalised cancer treatment." His … CityUHK's patented technologies, benefiting millions … CTC proteins and genes to enable cancer early screening, …

… methylation levels of 12 cervical cancer-related genes were detected using quantitative … . Disclosure Zhonghe Ke reports a patent 202310419890.9 pending to Suzhou … methylation detection of PAX1 gene in cervical cancer screening. Int J Gynecol …

… BioSciences Secures Another Landmark US Patent, Strengthening Its Position as the … profiles, including genes found to be associated with optimal cancer killing. Combinatorial … based immunotherapies. Our latest US patent further cements our leadership, ensuring …

… its pipeline as Keytruda’s patent cliff looms. It’s … for its advanced stomach cancer treatment in December. Chinese … also making waves in CRISPR gene-editing, thanks to companies … which rejected their China-developed cancer immunotherapy sintilimab. The key …